Interestingly, the clinical insulin modulator and diabetes drug, metformin[26] and the serotonin modulator Fluoxetine/Prozac that is used in depression treatment[29,30], each alter chemotherapy sensitivity in cancer cells. The gene discussed is INS; the disease is diabetes mellitus.